MTEX · Insider Trading
Mannatech Inc.
Every open-market purchase and sale reported by MTEX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Yasir Haider | Chief Financial Officer | A | +4,000 deriv. | — |
| 2026-06-05 | Seifrick A John | Director | A | +5,000 deriv. | — |
| 2026-06-05 | Robert Toth | Director | A | +5,000 deriv. | — |
| 2026-05-21 | Larry A Jobe | Director | Buy | +2,803 | +$11.55K |
| 2026-05-20 | Kevin Andrew Robbins | Director | Buy | +7,100 | +$29.61K |
| 2026-05-20 | Larry A Jobe | Director | Buy | +5,000 | +$21.00K |
| 2026-01-06 | J Stanley Fredrick | Director | A | +4,790 | +$40.00K |
| 2026-01-06 | Kevin Andrew Robbins | Director | A | +4,790 | +$40.00K |
| 2026-01-06 | Larry A Jobe | Director | A | +4,790 | +$40.00K |
| 2026-01-06 | Robert Toth | Director | A | +4,790 | +$40.00K |
| 2026-01-06 | Tyler Rameson | Director | A | +4,790 | +$40.00K |
| 2026-01-06 | Seifrick A John | Director | A | +4,790 | +$40.00K |
| 2025-08-28 | Erin Kemmler Barta | General Counsel | A | — | — |
| 2025-08-28 | Landen Granvel Fredrick | President and CEO | A | — | — |
| 2025-08-28 | James Clavijo | Chief Financial Officer | A | +10,000 deriv. | — |
| 2025-06-05 | Tyler Rameson | Director | A | — | — |
| 2025-06-05 | James Clavijo | Chief Financial Officer | A | +10,000 deriv. | — |
| 2025-06-05 | Erin Kemmler Barta | General Counsel | A | — | — |
| 2025-06-05 | Landen Granvel Fredrick | President and CEO | A | — | — |
| 2025-06-05 | J Stanley Fredrick | Director | A | — | — |
| 2025-03-17 | Robert Toth | Director | A | — | — |
| 2025-01-06 | Tyler Rameson | Director | A | +2,686 | +$39.99K |
| 2025-01-06 | Kevin Andrew Robbins | Director | A | +2,686 | +$39.99K |
| 2025-01-06 | J Stanley Fredrick | Director | A | +2,686 | +$39.99K |
| 2025-01-06 | Larry A Jobe | Director | A | +2,686 | +$39.99K |
| 2025-01-06 | Robert Toth | Director | A | +2,686 | +$39.99K |
| 2025-01-06 | Seifrick A John | Director | A | +2,686 | +$39.99K |
| 2024-11-22 | Robert Toth | Director | A | — | — |
| 2024-09-10 | Tyler Rameson | Director | Buy | +16,288 | +$126.23K |
| 2024-09-10 | Larry A Jobe | Director | Sell | −16,288 | −$126.23K |
| 2024-09-04 | J Stanley Fredrick | Director | A | +4,932 | +$40.00K |
| 2024-07-03 | James Clavijo | Chief Financial Officer | A | +4,500 deriv. | — |
| 2024-06-14 | Kevin Andrew Robbins | Director | A | +5,000 deriv. | — |
| 2024-06-14 | Larry A Jobe | Director | A | +5,000 deriv. | — |
| 2024-05-23 | Larry A Jobe | Director | Sell | −1,012 | −$7.69K |
| 2024-03-13 | Landen Granvel Fredrick | COO/Interim CFO | A | +8,187 | +$74.99K |
| 2024-01-05 | Tyler Rameson | Director | A | +4,932 | +$40.00K |
| 2024-01-05 | Kevin Andrew Robbins | Director | A | +4,932 | +$40.00K |
| 2024-01-05 | Larry A Jobe | Director | A | +4,932 | +$40.00K |
| 2024-01-05 | Seifrick A John | Director | A | +4,932 | +$40.00K |
| 2024-01-05 | J Stanley Fredrick | Director | A | +4,932 | +$40.00K |
| 2023-08-30 | Alfredo Bala | CEO and President | Sell | −1,000 | −$12.40K |
| 2023-08-21 | Larry A Jobe | Director | Sell | −1,217 | −$15.60K |
| 2023-07-06 | Alfredo Bala | CEO and President | Sell | −269 | −$3.44K |
| 2023-06-09 | Seifrick A John | Director | A | +5,000 deriv. | — |
| 2023-02-15 | Landen Granvel Fredrick | Chief Sales/Marketing Officer | M | +2,000 | +$11.44K |
| 2023-01-05 | Kevin Andrew Robbins | Director | A | +2,294 | +$39.98K |
| 2023-01-05 | Robert Toth | Director | A | +2,294 | +$39.98K |
| 2023-01-05 | Larry A Jobe | Director | A | +2,294 | +$39.98K |
| 2023-01-05 | Seifrick A John | Director | A | +1,338 | +$23.32K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| J Stanley Fredrick | Director | 356,975 | $2.81M |
| Tyler Rameson | Director | 301,883 | $2.37M |
| Robert Toth | Director | 91,130 | $716.28K |
| Larry A Jobe | Director | 70,000 | $550.20K |
| Kevin Andrew Robbins | Director | 33,333 | $262.00K |
| Seifrick A John | Director | 8,956 | $70.39K |
| Landen Granvel Fredrick | President and CEO | 3,975 | $31.24K |
| Erin Kemmler Barta | General Counsel | 3,000 | $23.58K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MTEX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.